Staburo @ European Statistical Forum in Munich

Nov 28, 2023
forum

On Tuesday, 14th November 2023, the Staburo team comprising Hannes Buchner, Laura Schlieker and Sarah Mwiberi Juckel attended the 14th European Statistical Forum held in Munich, Germany. The conference was organised by life science academy and attracted participants from both academia and industry all over Europe.

The theme of the conference was statistical methodology in precision medicine and the role of artificial intelligence. A wide range of topics all centered around precision medicine were presented including creation of fairer ML algorithms, quantification of uncertainty on ML systems, training a learner algorithm, biomarker threshold optimisation, application of polygenic scores in clinical trials as well as AI/ML and omics methods. The keynote speaker was Prof. Werner Brannath from the University of Bremen. He gave a presentation on the population-wise error rate (PWER), a novel type I error rate which has applications in clinical trials with multiple populations where there is a chance for multiple type I errors.

The conference concluded with an interactive Q & A session, in which speakers and attendees discussed the current and future roles of statistics, precision medicine and artificial intelligence in the pharmaceutical industry.

The conference also allowed for networking and intense discussions during breaks. We look forward to sharing our insights with our colleagues at Staburo.

More Articles

7th Staburo Health Data Science Summit 

7th Staburo Health Data Science Summit 

The 7th Staburo Health Data Science Summit brought together experts from the pharmaceutical and life sciences industries to explore the evolving role of biomarkers and data science in advancing precision medicine.  With contributions from leading organizations,...

read more
Staburo @ ISCB/GMDS Conference 2026

Staburo @ ISCB/GMDS Conference 2026

Staburo Team Selected to Present at ISCB/GMDS Conference 2026 We are pleased to share that Maria Stark, Senior Data Scientist, and the team representing Staburo in the GMDS Biostatistics Competition have been selected to present their work at the upcoming ISCB/GMDS...

read more
Biomarkers at Staburo

Biomarkers at Staburo

In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...

read more